NOVELION THERAPEUTICS INC. NVLN Income Statement

Novelion therapeutics inc. (NVLN)

Income statement / TTM

Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Net revenues
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net revenues
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of product sales
61,411	59,697	71,244	72,990	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net revenues
-	-	-	-	-	-	-	-	43,558	13,574	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Royalties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Cost of product sales
-	-	-	-	-	-	-	-	22,416	5,971	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Operating expenses:
Selling, general and administrative
82,177	79,831	89,884	92,931	95,710	96,472	88,313	70,080	48,040	29,525	15,855	15,859	18,539	16,222	22,979	22,201	19,145	17,682	10,060	9,348	7,060	6,986	8,001	8,994	13,056	15,082	12,660	13,684	14,071	17,059	22,402	23,743	0	0	0
Research and development
33,988	38,820	42,929	51,010	51,474	49,008	43,246	28,989	21,094	14,784	10,810	10,097	10,572	9,790	9,873	10,523	11,198	13,803	16,478	18,929	19,242	18,509	18,672	19,068	22,141	24,578	15,498	15,972	19,826	23,043	35,267	36,483	0	0	0
Depreciation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	955	963	1,037	1,165	1,213	1,269	1,313	1,292	1,312	1,321	0	0	0
Restructuring charges
-	-	2,146	51	-	2,536	2,541	2,485	1,451	0	0	0	0	-	-	-	-	744	927	1,281	1,780	2,031	13,249	0	0	-	0	-	-	-	0	-	-	-	-
Total operating expenses
118,316	120,802	134,959	143,992	148,269	148,016	134,100	101,554	70,585	44,309	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Termination fee (Note 3)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Termination fee (Note 3)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	28,392	30,493	29,040	28,490	31,923	44,368	50,906	54,675	36,024	26,176	33,872	41,394	65,599	71,557	0	0	0
Loss from operations
-44,579	-50,067	-65,061	-92,733	-86,611	-86,798	-87,194	-53,812	-49,443	-36,706	-26,157	-22,922	-26,256	-23,345	-1,614	-4,234	-2,075	-3,829	-28,392	-30,493	-29,040	-28,490	-31,923	-44,368	-50,906	-54,675	-57,609	-47,761	-42,772	-41,394	-35,429	-29,011	0	0	0
Interest expense, net
-55,122	-50,498	-44,817	-42,692	-40,711	-39,037	-31,921	-21,914	-12,247	-2,960	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value loss on investment
-	-	-	-	-	-	-	-	-	-10,740	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net foreign exchange loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-70	-124	13	-32	40	159	43	-8	-271	-634	-544	-148	448	-226	0	0	0
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	115	127	176	211	235	252	0	-	0	0	-	-	-	-	-	-	-
Fair value loss on investment (Notes 2(b))
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	1,136	1,505	0	0	0
Fair value change in contingent consideration (Notes 7, 14)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,427	2,498	3,536	2,865	3,687	6,456	7,068	8,215	0	0	0	-	-	-	-	-	-
Other expense, net
-2,083	-1,830	-2,429	-1,454	-651	-292	-1,580	-1,773	-1,870	-1,999	-154	-16	6	81	-603	-580	-538	-481	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from continuing operations before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,197	-25,699	-27,724	-25,053	-25,239	-27,866	-37,446	-43,519	-46,164	-47,249	-38,701	-32,417	-30,178	-21,734	-14,573	0	0	0
Fair value change in contingent consideration (Notes 7 and 10)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Other gains
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	60	697	685	665	613	42	399	0	0	0
Total other (expense) income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	2,693	2,769	3,987	3,251	4,057	6,922	7,387	8,511	10,360	9,060	10,355	11,216	13,695	14,438	0	0	0
Loss before provision for income taxes
-106,117	-106,728	-112,307	-136,879	-127,973	-126,127	-120,731	-77,535	-61,340	-52,405	-36,729	-33,357	-38,988	-22,987	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Benefit from (Provision for) income taxes
1,199	1,599	1,200	1,564	644	583	1,331	719	598	465	-99	19	19	22	19	-416	-398	-192	-29	512	631	599	331	-4,123	-4,014	-3,900	-5,036	-430	-212	1,201	2,333	1,833	0	0	0
Net Income (Loss) Attributable to Parent
-107,272	-108,300	-113,466	-138,402	-128,576	-126,710	-122,062	-78,254	-61,938	-52,870	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-24,497	-16,406	0	0	0
Loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-25,838	-28,197	-33,323	-39,505	-42,264	-42,880	0	0	-	0	-	-	-	-
(Loss) income from discontinued operations, net of income taxes (Note 12)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	967	94,193	0	0	-	0	-	-	-	-	-	-	-	-
Net loss and comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) Income from discontinued operations, net of income taxes (Note 8)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	-
Net loss and comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	61,438	52,530	0	-	0	0	-	-	-	-	-	-	-
Continuing operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.10	-0.17	-	-0.11	-0.15	-0.12	-0.13	-0.15	-0.25	-0.25	-0.19	-	-0.17	-	-	-	-
Discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	-	0.02	0.00	0.00	0.00	-0.01	1.86	-0.08	-0.02	-	-0.01	-	-	-	-
Net loss per common share—basic and diluted (in usd per share)
-1.67	-1.01	-1.32	-1.67	-1.76	-1.32	-2.67	-1.15	-1.67	-1.58	-0.56	-0.48	-2.07	-1.82	-0.05	-0.21	-0.12	0.00	-0.10	-0.17	-0.13	-0.10	-0.14	-0.12	-0.13	-0.16	1.61	-0.33	-0.21	-0.14	-0.18	-0.12	-0.17	-0.01	-0.02
Weighted-average shares outstanding—basic and diluted (in shares)
19,022	18,932	18,854	18,759	18,703	18,667	18,648	18,609	18,540	13,441	10,565	10,565	10,565	-114,109	52,829	51,779	51,237	-61,384	51,151	51,082	51	51,082	51,082	50,883	50,589	102,222	50	49,191	48,984	-	-	-	-	-	-
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49	50	51,023	51,656	53,009
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49	50	51,023	51,656	53,009